Get started
Author

Anoek Friskes

Observed name: A. Friskes
ORCID: 0000-0002-9845-3715
Observed ORCID: 0000-0002-9845-3715
OpenAlex ID: A5090302884
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024 · Matheus Henrique Dias, Anoek Friskes, et al. · Cancer Discovery · 60
PDF
Double-strand break toxicity is chromatin context independent
2022 · Anoek Friskes, Lisa Koob, et al. · Nucleic Acids Research · 32
Widespread chromatin context-dependencies of DNA double-strand break repair proteins
2024 · Xabier Vergara, Anna G. Manjón, et al. · Nature Communications · 25
Perturbations in 3D genome organization can promote acquired drug resistance
2023 · Anna G. Manjón, Stefano Giustino Manzo, et al. · Cell Reports · 25
PDF
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
2024 · Ruben Schep, Max Trauernicht, et al. · Nucleic Acids Research · 21
PDF
MND1 enables homologous recombination in somatic cells primarily outside the context of replication
2023 · Lisa Koob, Anoek Friskes, et al. · Molecular Oncology · 17
PDF
Unexpected gene activation following CRISPR‐Cas9‐mediated genome editing
2021 · Anna G Manjón, Simon Linder, et al. · EMBO Reports · 10
PDF
Centriole structural integrity defects are a crucial feature of hydrolethalus syndrome
2025 · Ana Curinha, Zhaoyu Huang, et al. · The Journal of Cell Biology · 9
PDF
Visualizing homology search in living cells
2025 · Anoek Friskes, Melanie Snoek, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
SRBD1, a highly conserved gene required for chromosome individualization
2025 · Jonne A. Raaijmakers, Louise M.E. Janssen, et al. · Cell Reports · 3
A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapy
2024 · Apostolos Menegakis, Claire Vennin, et al. · Radiotherapy and Oncology · 2
PDF
The dynamics of RAD51 foci formation and elongation in living human cells
2026 · Anoek Friskes, Melanie Snoek, et al. · Nucleic Acids Research · 1
Data from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024 · Matheus Henrique Dias, Anoek Friskes, et al. · 1
Tubulin acetylation regulates nuclear shape fluctuations and DNA repair
2026 · Sam Wallis, Wai Yiu Tse, et al. · Nature Cell Biology
Figure S5 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Figure S7 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Figure S8 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Figure S6 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Table S1 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Figure S3 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Table S4 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Table S5 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Figure S2 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Figure S10 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Table S7 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2026 · Matheus Henrique Dias, Anoek Friskes, et al.
Works count: 61
Citation count: 211
H-index: 8
I10-index: 7
Year
Topic
Type